Picard MedicalPMI -1.63%4 PS Ratio is 2.12 as of Jul. 03, 2026, which is 91% below its 10-year median of 22.70. GuruFocus rates PMI with a GF Score™ of 4/100. The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Picard Medical ranks better than 60.75% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Picard Medical's share price is $0.1694.
Picard Medical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.08. Hence, Picard Medical's PS Ratio for today is 2.12.
The historical rank and industry rank for Picard Medical's PS Ratio or its related term are showing as below:
PMI'
s PS Ratio Range Over the Past 10 Years
Min: 1.78 Med: 22.7 Max: 140.32
Current: 2.12
During the past 4 years, Picard Medical's highest PS Ratio was 140.32. The lowest was 1.78. And the median was 22.70.
PMI's PS Ratio is ranked better than 60.75% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs PMI: 2.12
During the past 12 months, the average Revenue per Share Growth Rate of Picard Medical was 86.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 33.60% per year.
During the past 4 years, Picard Medical's highest 3-Year average Revenue per Share Growth Rate was 33.60% per year. The lowest was 33.60% per year. And the median was 33.60% per year.
Back to Basics: PS Ratio
Picard Medical (AMEX:PMI) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Picard Medical PS Ratio Related Terms
Picard Medical PS Ratio Historical Data
* Premium members only.
The historical data trend for Picard Medical's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Picard Medical's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Picard Medical PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Picard Medical's PS Ratio distribution charts can be found below:
* The bar in red indicates where Picard Medical's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Picard Medical's Share Price of today is $0.1694. Picard Medical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.08.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Picard Medical (PMI) has a PS Ratio of 2.12 as of Jul. 03, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Picard Medical and its competitors. This is 91% below median its historical median of 22.70. Over the past decade, Picard Medical's PS Ratio has ranged from 1.78 to 140.32. According to the industry distribution chart, Picard Medical ranks #316 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 39.3%.
Is Picard Medical's PS Ratio too high?
Picard Medical's current PS Ratio of 2.12 is 91% below median its 10-year median of 22.70. Over the past 10 years, this metric has ranged from a low of 1.78 to a high of 140.32. The Medical Devices & Instruments industry median PS Ratio is 2.94. Picard Medical's value of 2.12 is 27.9% below this industry median. Based on the distribution chart, Picard Medical ranks #316 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Picard Medical has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Picard Medical's PS Ratio compare to ADGM and SINT?
According to the Medical Devices & Instruments industry distribution chart, Picard Medical ranks #316 out of 805 companies for PS Ratio. This puts Picard Medical in the upper half of its industry. The industry median PS Ratio is 2.94. Picard Medical's value of 2.12 is 27.9% below this benchmark. Historically, Picard Medical's own PS Ratio has ranged from 1.78 to 140.32 over the past decade. While the company's 10-year median is 22.70 vs. the industry median of 2.94, Picard Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Picard Medical's current PS Ratio of 2.12 is 27.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Picard Medical and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Picard Medical's current PS Ratio is 2.12, which is 91% below median its own 10-year median of 22.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Picard Medical stock overvalued right now?
Picard Medical (PMI) has a current PS Ratio of 2.12. The current PS Ratio is 2.12, which is 91% below median its 10-year median of 22.70 and 27.9% below the Medical Devices & Instruments industry median of 2.94. Picard Medical's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Picard Medical (PMI), the current PS Ratio is 2.12 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
4GF Score
Get the complete analysis for PMI
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMI has been successfully added to your 
